Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer’s disease

The need for preventive therapies that interrupt the progression of Alzheimer’s disease (AD) before the onset of symptoms or when symptoms are emerging is urgent and has spurred the ongoing development of dise…